Name: UMIN ID:
Unique ID issued by UMIN | UMIN000041004 |
---|---|
Receipt number | R000046804 |
Scientific Title | To establish of optimal antiemetic therapy for trastuzumab deruxtecan therapy-induced nausea and vomiting in patients with breast cancer:an open-label, randomized pilot study |
Date of disclosure of the study information | 2020/07/06 |
Last modified on | 2024/01/07 17:45:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/07/05 10:24:51 | ||
2 | Update | 2023/07/07 09:13:53 | Recruitment status |
|
3 | Update | 2024/01/07 17:44:23 | Recruitment status |
|
4 | Update | 2024/01/07 17:45:00 | Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results |